Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Kovai Medical Center and Hospital Limited (KMCH) is a multi‑locational, multi‑disciplinary super‑speciality healthcare provider headquartered in Coimbatore, operating about 2,250 beds across primary and satellite centres and running a medical college under KMCH Institute of Health Sciences & Research. The company provides tertiary care across more than 30 medical departments and 11 operation theatres.
Financially, KMCH reported total revenue of INR 161,388.41 lakhs for year ended 31 March 2026, up from INR 139,321.72 lakhs a year earlier, and delivered profit after tax of INR 24,446.00 lakhs, generating an approximate PAT margin of 15.1%, signalling stable top‑line growth and resilient operating leverage in tertiary care services.
Operationally, the company is investing in high‑end clinical technology and procedures — including EnSite X EP platform, CORI robotics with AI capabilities, additional cath labs and pioneering cryoablation, complex interventional radiology and lung transplant programs — which position KMCH as a clinical leader in Southern India and a referral centre for advanced interventions.
Corporate disclosure included a corrigendum correcting an inadvertent arithmetic error in tax for the March 2026 quarter, with management noting full‑year figures were unaffected and committing to stronger controls. The correction reduced quarterly tax expense from INR 2,459.20 lakhs to INR 2,092.48 lakhs, demonstrating transparent governance and timely remediation.
Healthcare Services
Hospital
6,434 Cr
Low Risk
25.5
60.3
0.9
4.9
6,435.00
5,010.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
223.85 | 9,669 Cr | 32.58 | 4.81 | 0.00 | 12.77 | 17.33 | 10.55 | ||
983.20 | 9,474 Cr | 52.15 | 5.05 | 0.00 | 9.85 | 11.09 | 7.65 | ||
605.40 | 9,039 Cr | 271.76 | 6.79 | 0.00 | 2.90 | 7.81 | 0.85 | ||
263.35 | 8,633 Cr | 46.26 | 5.30 | 0.08 | 11.43 | 12.76 | 7.29 | ||
732.50 | 7,926 Cr | 180.86 | 8.86 | 0.00 | 11.10 | 10.73 | 0.00 | ||
5881.05 | 6,434 Cr | 25.46 | 4.88 | 0.26 | 18.53 | 20.76 | 12.41 | ||
285.30 | 4,516 Cr | 39.26 | 4.91 | 0.16 | 11.59 | 13.75 | 7.20 | ||
| Median: 7 Co. | — | 605.40 | 8,633 Cr | 46.26 | 5.05 | 0.00 | 11.43 | 12.76 | 7.29 |
Upcoming Result Date: Nov 10, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Bearish
3
Neutral
6
Bullish
5
Bearish
5
Neutral
6
Bullish
35
Bearish
2
Neutral
0
Bullish
30
Kovai Medical Center & Hospital Ltd (KOVAI) is currently trading at 5,981.30 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Kovai Medical Center and Hospital Limited (KMCH) is a multi‑locational, multi‑disciplinary super‑speciality healthcare provider headquartered in Coimbatore, operating about 2,250 beds across primary and satellite centres and running a medical college under KMCH Institute of Health Sciences & Research. The company provides tertiary care across more than 30 medical departments and 11 operation theatres. Financially, KMCH reported total revenue of INR 161,388.41 lakhs for year ended 31 March 2026, up from INR 139,321.72 lakhs a year earlier, and delivered profit after tax of INR 24,446.00 lakhs, generating an approximate PAT margin of 15.1%, signalling stable top‑line growth and resilient operating leverage in tertiary care services. Operationally, the company is investing in high‑end clinical technology and procedures — including EnSite X EP platform, CORI robotics with AI capabilities, additional cath labs and pioneering cryoablation, complex interventional radiology and lung transplant programs — which position KMCH as a clinical leader in Southern India and a referral centre for advanced interventions. Corporate disclosure included a corrigendum correcting an inadvertent arithmetic error in tax for the March 2026 quarter, with management noting full‑year figures were unaffected and committing to stronger controls. The correction reduced quarterly tax expense from INR 2,459.20 lakhs to INR 2,092.48 lakhs, demonstrating transparent governance and timely remediation.
Over the past 52 weeks, Kovai Medical Center & Hospital Ltd has traded between a low of ₹5,010.00 and a high of ₹6,435.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Kovai Medical Center & Hospital Ltd has a market capitalization of approximately 6,433.87. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Kovai Medical Center & Hospital Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 25.46 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 6,433.87 Cr, Kovai Medical Center & Hospital Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Kovai Medical Center & Hospital Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Kovai Medical Center & Hospital Ltd is 25.46. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Net profit was ₹69.09 crore for the quarter ended June 30, 2026, up from ₹57.23 crore in the year-ago quarter.
